Study of EVO756 in Adults With Migraine
for Migraine
Sites in Toms River +25 more locations
Sponsor: Evommune, Inc.
Sex: All·Age: 18 - 64
Code: NCT07616128·Phase 2·Recruiting·Listed Jun 2026
Paid Clinical Trials in New Jersey
New Jersey has 1,726 paid clinical trials enrolling now across cities including New Brunswick, Middletown and Basking Ridge. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
1,560 clinical trials
Get a weekly email when new trials open in New Brunswick, NJ.
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for Rhinovirus Infection
Sites in Hamilton +33 more locations
Sponsor: Altesa Biosciences, Inc.
Sex: All·Age: 40 - 85
Code: NCT07610395·Phase 2·Recruiting·Listed May 2026
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
for Lupus Nephritis
Sites in West Long Branch +26 more locations
Sponsor: Aurinia Pharmaceuticals Inc.
Sex: All·Age: 18 - 75
Code: NCT07611214·Phase 4·Recruiting·Listed May 2026
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for Pancreatic Cancer
Drug: Atebimetinib
Sites in Belleville +36 more locations
Sponsor: Immuneering Corporation
Sex: All·Age: 18+
Code: NCT07562152·Phase 3·Recruiting·Listed May 2026
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
for Depressive Disorder, Major
Drug: Seltorexant
Sites in Marlton +30 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18 - 74
Code: NCT07573176·Phase 3·Recruiting·Listed May 2026
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
for Diabetic Retinopathy
Drug: Surabgene Lomparvovec
Sites in Bloomfield +28 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07592273·Phase 2, Phase 3·Recruiting·Listed May 2026
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
for Gout
Drug: Dotinurad
Sites in Sparta +37 more locations
Sponsor: Crystalys Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07535034·Phase 2·Recruiting·Listed Apr 2026
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Drug: Teclistamab
Sites in East Brunswick +34 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07518186·Phase 3·Recruiting·Listed Apr 2026
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
for Atrial Fibrillation
Sites in New Brunswick +29 more locations
Sponsor: Biosense Webster, Inc.
Sex: All·Age: 18 - 80
Code: NCT07523750·Recruiting·Listed Apr 2026
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for HR+/HER2- Breast Cancer
Sites in East Brunswick, Florham Park +34 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT07492641·Phase 3·Recruiting·Listed Mar 2026
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
for Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Drug: ASP546C
Sites in Hackensack +13 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT07488676·Phase 1, Phase 2·Recruiting·Listed Mar 2026
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
for Ras-mutated Metastatic Colorectal Cancer
Drug: Bevacizumab
Sites in New Brunswick, Florham Park +11 more locations
Sponsor: Oncolytics Biotech
Sex: All·Age: 18+
Code: NCT07446322·Phase 2·Recruiting·Listed Mar 2026
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for ER+, HER 2- Breast Cancer
Sites in East Brunswick +10 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18 - 99
Code: NCT07540572·Phase 1·Recruiting·Listed Apr 2026
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: FWY003
Sites in Toms River +14 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 50+
Code: NCT07441642·Phase 2·Recruiting·Listed Mar 2026
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
for Endometrial Cancer
Sites in Hackensack +11 more locations
Sponsor: Whitehawk Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07444814·Phase 1·Recruiting·Listed Mar 2026
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
for Lyme Disease
Sites in Flemington +18 more locations
Sponsor: Pfizer
Sex: All·Age: 7+·Accepts healthy volunteers
Code: NCT07500506·Phase 3·Recruiting·Listed Mar 2026
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
for Schizophrenia
Drug: KarXT
Sites in Neptune City +48 more locations
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All·Age: 5 - 17
Code: NCT07424404·Phase 3·Recruiting·Listed Feb 2026
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
for Advanced Urothelial Cancer
Drug: GB-4362
Sites in New Brunswick +9 more locations
Sponsor: Generate Biomedicines
Sex: All·Age: 18+
Code: NCT07484022·Phase 1·Recruiting·Listed Mar 2026
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
for Knee Cartilage Defects
Sites in Westwood +27 more locations
Sponsor: Medipost, Inc.
Sex: All·Age: 18 - 75
Code: NCT07339111·Phase 3·Recruiting·Listed Jan 2026
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
for Glioblastoma (GBM)
Sites in New Brunswick, Hackensack +27 more locations
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07326566·Phase 2·Recruiting·Listed Jan 2026
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
for Multiple Sclerosis
Drug: Frexalimab
Sites in Teaneck +21 more locations
Sponsor: Sanofi
Sex: All·Age: 18 - 60
Code: NCT07325292·Phase 3·Recruiting·Listed Jan 2026
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis
for Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
Drug: Vamifeport
Sites in Flemington +18 more locations
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT07332091·Phase 2·Recruiting·Listed Jan 2026
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for Non-small Cell Lung Cancer (NSCLC)
Sites in East Brunswick +18 more locations
Sponsor: Genmab
Sex: All·Age: 18+
Code: NCT07288177·Phase 2·Recruiting·Listed Dec 2025
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for NSCLC Adenocarcinoma
Sites in East Brunswick +16 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07277413·Phase 1·Recruiting·Listed Dec 2025
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
for Hepatocellular Carcinoma (HCC)
Drug: Ipilimumab
Sites in Hackensack +10 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07291076·Phase 1, Phase 2·Recruiting·Listed Dec 2025
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
for Low Grade Upper Tract Urothelial Carcinoma
Sites in Sewell +16 more locations
Sponsor: Tyra Biosciences, Inc
Sex: All·Age: 18+
Code: NCT07265947·Phase 2·Recruiting·Listed Dec 2025
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
for Focal Seizures
Sites in New Brunswick, Edison +22 more locations
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 12 - 75
Code: NCT07233239·Phase 1·Recruiting·Listed Nov 2025
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for Small Cell Lung Cancer Extensive Stage
Drug: Gocatamig
Sites in Hackensack +12 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07227597·Phase 1, Phase 2·Recruiting·Listed Nov 2025
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
for Squamous Non-small Cell Lung Cancer
Drug: Intismeran autogene
Sites in Paramus +10 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07221474·Phase 2·Recruiting·Listed Oct 2025
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
for Major Depressive Disorder (MDD)
Sites in Marlton +22 more locations
Sponsor: Draig Therapeutics Ltd
Sex: All·Age: 18 - 75
Code: NCT07300969·Phase 2·Recruiting·Listed Dec 2025
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Sites in Hillsborough +22 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07266831·Phase 2, Phase 3·Recruiting·Listed Dec 2025
A Gaucher Disease Gene Therapy Trial With FLT201
for Gaucher Disease Type 1
Sites in Hackensack +15 more locations
Sponsor: Spur Therapeutics
Sex: All·Age: 18+
Code: NCT07223944·Phase 3·Recruiting·Listed Nov 2025
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
for GRIN-related Neurodevelopmental Disorder
Sites in Hackensack +16 more locations
Sponsor: GRIN Therapeutics, Inc.
Sex: All·Age: 1 Month - 18
Code: NCT07224581·Phase 3·Recruiting·Listed Nov 2025
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
for Non-small Cell Lung Cancer
Drug: Calderasib
Sites in Hackensack +10 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07190248·Phase 3·Recruiting·Listed Sep 2025
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for Microvascular Inflammation
Sites in West Orange +21 more locations
Sponsor: Biogen
Sex: All·Age: 18 - 74
Code: NCT07219043·Phase 2·Recruiting·Listed Oct 2025
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for Advanced Biliary Tract Cancer
Sites in New Brunswick +17 more locations
Sponsor: J-Pharma Co., Ltd.
Sex: All·Age: 18+
Code: NCT07265674·Phase 3·Recruiting·Listed Dec 2025
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for Breast Cancer
Drug: Giredestrant
Sites in New Brunswick +25 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT07100106·Phase 1, Phase 2·Recruiting·Listed Aug 2025
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
for Breast Cancer
Sites in Florham Park +15 more locations
Sponsor: Tempus AI
Sex: All·Age: 18 - 99
Code: NCT07211178·Recruiting·Listed Oct 2025
A Study to Evaluate the Effect of KarXT on Urological Safety
for Schizophrenia
Drug: KarXT
Sites in Marlton +12 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18 - 65
Code: NCT07221877·Phase 4·Recruiting·Listed Oct 2025
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for Relapsed/Refractory Primary Central Nervous System Lymphoma
Drug: Rituximab
Sites in Hackensack, Summit +22 more locations
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All·Age: 18+
Code: NCT07104032·Phase 3·Recruiting·Listed Aug 2025